Melbourne, Victoria --News Direct-- Starpharma Holdings Limited Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) CEO Dr Jackie Fairley speaks with Proactive from the ASX Small and Mid-Cap Conference March 2023. The company is focused on the development of pharmaceutical and medical products for unmet patient needs, including in the areas of oncology and infectious diseases. Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 [email protected] View source version on newsdirect.com: https://newsdirect.com/news/starpharma-with-proactive-at-the-asx-small-and-mid-cap-conference-595383537
Starpharma with Proactive at the ASX Small and Mid-Cap Conference
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...